Christopher Bloomstran Semper Augustus Investments Group
Christopher Bloomstran is the president of Semper Augustus Investments Group, a value-oriented firm with a multi-decade focus on capital preservation and thoughtful security selection. He is known for detailed annual letters that discuss portfolio construction, accounting quality, and long-term ownership of businesses such as Berkshire Hathaway. Bloomstran’s work is popular among investors who prefer process transparency over short-term trading narratives.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$5.52M |
| 2 |
Usg
USG
|
+$758K |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$633K |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$313K |
| 5 |
Starbucks
SBUX
|
+$236K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 49.24% |
| 2 | Materials | 12.02% |
| 3 | Consumer Discretionary | 8.99% |
| 4 | Industrials | 7.91% |
| 5 | Consumer Staples | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class B
BRK.B
$1.16T
| $37M | 23.74% |
181,032
-3,030
| -2% | -$633K |
2013 Q2
22 quarters
|
|
|
2
Berkshire Hathaway Class A
BRK.A
$1.16T
| $26M | 16.71% |
85
-1
| -1% | -$313K |
2013 Q2
22 quarters
|
|
|
3
Starbucks
SBUX
$118B
| $11.1M | 7.15% |
172,724
-3,768
| -2% | -$236K |
2018 Q2
2 quarters
|
|
4
Mercury Insurance
MCY
$5.67B
| $7.81M | 5.02% |
150,972
-3,418
| -2% | -$186K |
2013 Q2
22 quarters
|
|
5
ExxonMobil
XOM
$764B
| $7.64M | 4.91% |
111,989
-2,040
| -2% | -$160K |
2013 Q2
22 quarters
|
|
6
Dollar General
DG
$29.2B
| $6.05M | 3.89% |
55,987
-1,634
| -3% | -$177K |
2017 Q1
7 quarters
|
|
7
Newmont
NEM
$111B
| $6.05M | 3.88% |
174,526
-1,150
| -0.7% | -$37.3K |
2013 Q2
22 quarters
|
|
|
8
DELISTED
Usg
USG
| $5.56M | 3.57% |
130,280
-17,712
| -12% | -$758K |
2018 Q2
2 quarters
|
|
9
Costco
COST
$449B
| $3.98M | 2.55% |
19,516
-300
| -2% | -$67K |
2013 Q2
22 quarters
|
|
10
Cummins
CMI
$68.8B
| $3.92M | 2.52% |
29,295
-740
| -2% | -$104K |
2018 Q3
1 quarter
|
|
|
11
NXP Semiconductors
NXPI
$65.4B
| $3.85M | 2.48% |
52,592
+22,214
| +73% | +$1.76M |
2018 Q3
1 quarter
|
|
12
SEACOR Marine Holdings
SMHI
$268M
| $3.78M | 2.43% |
321,148
-7,710
| -2% | -$137K |
2017 Q2
6 quarters
|
|
13
Hexcel
HXL
$5.89B
| $3.71M | 2.39% |
64,762
-1,516
| -2% | -$91.4K |
2016 Q2
10 quarters
|
|
|
GG
14
DELISTED
Goldcorp Inc
GG
| $3.6M | 2.31% |
367,048
-13,022
| -3% | -$126K |
2013 Q2
22 quarters
|
|
15
Kinross Gold
KGC
$23.7B
| $3.51M | 2.26% |
1,083,752
-23,206
| -2% | -$64.9K |
2013 Q2
22 quarters
|
|
16
Merck
MRK
$369B
| $3.26M | 2.1% |
44,774
| – | – |
2013 Q2
22 quarters
|
|
17
Nike
NKE
$57.4B
| $2.88M | 1.85% |
38,792
-826
| -2% | -$61.8K |
2017 Q2
6 quarters
|
|
18
Travelers Companies
TRV
$81.2B
| $2.4M | 1.54% |
20,000
| – | – |
2013 Q2
22 quarters
|
|
19
Walt Disney
DIS
$192B
| $2.35M | 1.51% |
21,468
-461
| -2% | -$52.4K |
2018 Q2
2 quarters
|
|
20
Equinor
EQNR
$115B
| $2.28M | 1.47% |
107,815
-2,425
| -2% | -$59.5K |
2013 Q2
22 quarters
|
|
21
American Express
AXP
$214B
| $2.03M | 1.3% |
21,284
-477
| -2% | -$49.9K |
2015 Q1
15 quarters
|
|
|
AVX
22
DELISTED
AVX Corporation
AVX
| $1.45M | 0.93% |
95,058
-2,322
| -2% | -$37.5K |
2013 Q2
22 quarters
|
|
23
WaFd
WAFD
$2.17B
| $1.44M | 0.93% |
54,022
-1,182
| -2% | -$33.2K |
2013 Q2
22 quarters
|
|
24
Coca-Cola
KO
$405B
| $1.42M | 0.91% |
30,000
| – | – |
2013 Q2
22 quarters
|
|
25
Intel
INTC
$350B
| $970K | 0.62% |
20,677
-484
| -2% | -$22.7K |
2013 Q2
22 quarters
|
|
Similar funds
Christopher Bloomstran's Q4 2018 Portfolio in Review
As of Q4 2018, Christopher Bloomstran held 29 positions worth $156M, down 10% from $173M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Christopher Bloomstran withdrew a net $7.16M in Q4 2018, closing 1 position and reducing 22 holdings. Its most notable exit was Sanofi, an estimated $5.52M position sold in full.
By sector, the portfolio is most concentrated in Financials at 49% of assets, up from 47% a quarter earlier, followed by Materials and Consumer Discretionary.
Against the trend, Christopher Bloomstran added an estimated $1.76M to NXP Semiconductors.
- Christopher Bloomstran added most to NXP Semiconductors in Q4 2018, an estimated $1.76M increase.
- Christopher Bloomstran's biggest Q4 2018 reduction was Usg, cutting an estimated $758K.
- Christopher Bloomstran fully exited Sanofi in Q4 2018, selling an estimated $5.52M.
- Christopher Bloomstran's ten largest holdings make up 74% of its $156M portfolio in Q4 2018.
- Christopher Bloomstran opened 0 new positions and closed 1 in Q4 2018.
- Christopher Bloomstran's portfolio value fell 10% quarter-over-quarter to $156M.
Based on Semper Augustus Investments Group's 13F filing for Q4 2018, filed 13 Feb 2019.